-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Guangzhou Privat Technology Co.
Decentralized
Privat and FIND will carry out strategic cooperation around the decentralization of molecular detection platforms to improve the level of health care in low- and middle-income areas and make diagnostic technology universally accessible to all
"Covid-19 has accelerated technological development and has had a huge impact on
Help the sinking
As a new generation of molecular POC detection platform, Priva MiniDock has the characteristics of precision, convenience and decentralization, helping medical resources sink and making the application scenarios more extensive
"Promoting the innovation of diagnostic technology and giving people in low- and middle-income areas equal rights to high-quality diagnostic tools is a common goal of us and FIND," said Mr.
About FIND
As the Global Diagnostics Alliance, the Foundation for Innovative Diagnostics (FIND) aims to ensure that reliable diagnosis
About Privat
Founded in 2017 and located in Guangzhou, Yangcheng, Privat is committed to using a new generation of genetic technology to develop independent and innovative molecular diagnostic products, providing complete solutions from core protein research and development, molecular detection methodology research and development, to molecular POCT detection products
Privat was founded by the first batch of national high-level imported talents, the team consists of a number of professors, postdoctoral fellows, senior talents in the collective external diagnostic industry and protein engineering industry, and more than 60% of employees are currently engaged in R&D related positions
Based on the breakthrough independent intellectual property rights OF RHAM technology, Privat has developed molecular POCT instruments and detection card products
for human respiratory tract infections, reproductive tract infections, pet disease detection and so on.
Privat has applied for more than 80 patents and authorized more than 20 patents around a variety of technologies; 15 test kits are CE certified and 1 is IVDR certified
.
For more details, please visit the